More oncological safety during breast-conserving operations at the BreastCentre Zurich thanks to innovative navigation with the "Breast Cancer Locator"
Prof. Dr. med. Hisham Fansa
April 5, 2024
4 min
The innovative navigation tool at the BrustCentrum Zürich is revolutionising the treatment of breast-conserving surgery through precision, safety and better aesthetic results. As the only breast centre in Zurich to offer this procedure, we are proud to give our patients access to this first-class technology.
Our breast centre has taken part in an international study that has introduced an innovative navigation tool for breast-conserving breast cancer operations: "Breast Cancer Locator" (BCL). This innovative method, developed in the USA, is now available to all patients of the BreastCentre Zurich at the Zollikerberg Hospital site and marks a significant advance in the treatment of breast cancer. As the only breast centre in Zurich to offer this procedure, we are proud to be able to provide our patients with ever greater oncological safety in breast-conserving operations.
Precision and safety: how the BCL tool is revolutionising the treatment of breast cancer
The BCL first enables precise imaging of the breast tumour using magnetic resonance imaging (MRI). This data is then used to create a three-dimensional image of the tumour on the computer. This gives our surgeons precise information about the location of the tumour and how much tissue needs to be removed and how much can be preserved. By using the BCL, we can mark tumours extremely precisely and remove them in an oncologically safe manner. This not only ensures a safe operation for our patients, but also leads to a significant reduction in follow-up operations.
Aesthetic results and improved quality of life
By precisely removing the affected area and sparing unaffected breast tissue, we can also achieve better aesthetic results and improve our patients' quality of life. The feedback from our patients so far has been extremely positive and all of them would opt for this type of surgery again.
With the BCL tool, we are setting a new standard in the treatment of breast cancer and giving our patients new hope in the fight against this disease.
Weitere Beiträge
Latest news
Fast track in the emergency centre: efficient care for patients
With the opening of the new "fast track" in the interdisciplinary emergency centre, Zollikerberg Hospital is taking an important step towards managing the increasing demand in emergencies in an efficient and patient-oriented manner. The new treatment pathway enables patients with less complex but urgent concerns to be treated quickly and in a targeted manner, while at the same time relieving the pressure on the core emergency centre.
In an interview with PD Dr Sima Djalali, Head Physician, Department of Internal Medicine, Emergency Medicine, we find out what considerations were behind the project, how the fast track works in everyday life and what difference it makes for patients and the treatment team.
Latest news
We are celebrating 10 years of Women's Permanence Zurich and would like to thank you
We have been serving our patients at Frauen-Permanence Zürich am Stadelhofen since 5 October 2015 - as the first practice for gynaecology and obstetrics in the city. Since then, our team has been providing specialist medical care every day, with or without an appointment. We are looking forward to moving into the new Calatrava building "Haus zum Falken" in spring 2026 and would like to thank you, our patients, for your trust and loyalty.
Latest news
Black skin cancer: recognising, preventing and treating risks
In summer, when the sun is often at its highest and temperatures are at their peak, proper skin protection is essential. It is precisely now that we should take a conscious look at our skin health and inform ourselves about the risks of skin cancer. The focus today is on black skin cancer, also known as malignant melanoma. The incidence of melanoma has risen worldwide in recent decades - including in Switzerland - and is curable by surgery in over 80 per cent of cases. The main cause: UV radiation. In this interview, Dr Sora Linder, our specialist in dermatosurgery (surgical dermatology) and Head of Plastic Surgery Zurich, provides valuable insights and advice on the subject of melanoma.